ZA964879B - Starch microsphere anti migraine composition. - Google Patents

Starch microsphere anti migraine composition.

Info

Publication number
ZA964879B
ZA964879B ZA9604879A ZA964879A ZA964879B ZA 964879 B ZA964879 B ZA 964879B ZA 9604879 A ZA9604879 A ZA 9604879A ZA 964879 A ZA964879 A ZA 964879A ZA 964879 B ZA964879 B ZA 964879B
Authority
ZA
South Africa
Prior art keywords
starch microsphere
anti migraine
composition
microsphere anti
migraine composition
Prior art date
Application number
ZA9604879A
Other languages
English (en)
Inventor
Lisbeth Illum
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of ZA964879B publication Critical patent/ZA964879B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
ZA9604879A 1995-06-08 1996-06-07 Starch microsphere anti migraine composition. ZA964879B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP95201504 1995-06-08

Publications (1)

Publication Number Publication Date
ZA964879B true ZA964879B (en) 1997-12-08

Family

ID=8220362

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9604879A ZA964879B (en) 1995-06-08 1996-06-07 Starch microsphere anti migraine composition.

Country Status (5)

Country Link
KR (1) KR19990021931A (xx)
AU (1) AU6003896A (xx)
IL (1) IL118606A0 (xx)
WO (1) WO1996041632A1 (xx)
ZA (1) ZA964879B (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2771929B1 (fr) * 1997-12-09 2001-02-23 Biovector Therapeutics Utilisation dans une composition pharmaceutique pour l'administration par voie nasale de particules hydrophiles pour la delivrance d'agents actifs au systeme nerveux central
BR0307333A (pt) 2002-02-01 2004-12-07 Pfizer Prod Inc Métodos para a preparação de dispersões homogéneas de fármacos sólidos amorfos atomizados utilizando um sistema de secagem por pulverização
CN103409250A (zh) * 2013-07-18 2013-11-27 吴江市利达上光制品有限公司 一种水果专用洗涤精的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9116610D0 (en) * 1991-08-01 1991-09-18 Danbiosyst Uk Preparation of microparticles
SI9300097B (en) * 1992-02-27 2001-12-31 Janssen Pharmaceutica Nv (benzodioxan, benzofuran or benzopyran) alkylamino) alkyl substituted guanidines

Also Published As

Publication number Publication date
KR19990021931A (ko) 1999-03-25
IL118606A0 (en) 1996-10-16
AU6003896A (en) 1997-01-09
WO1996041632A1 (en) 1996-12-27

Similar Documents

Publication Publication Date Title
ZA967315B (en) Biphenylamides.
ZA964473B (en) Endoparasiticidal compositions.
CY2408B1 (en) Paroxetine controlled release compositions.
ZA9610245B (en) Neuroprotective agents.
ZA964468B (en) Triazolylmethyl-cyclopentanols.
CY2440B1 (en) Process improvement in the synthesis of N-A3-(3-cyanopyrazolo A1,5-aUpyrimidin-7-yl)phenylU-N-ethyl-acetamide.
ZA962167B (en) Deodorant compositions.
AU4836297A (en) Self-enhancing, pharmacologically controllable expression systems
ZA961449B (en) Isoxazolylbenzoyl derivatives.
EP0676766A3 (en) Comprehensive data bus architecture.
ZA969973B (en) 2-thioxo-imidazolidin-4-one derivatives.
AU6123196A (en) N-aryl-1,2,4-triazolin-5-ones
DE69610844D1 (en) Hydroformylierungsverfahren.
ZA967741B (en) Diarylalkenylamine derivatives.
ZA9811537B (en) Methods for regulating phagocytosis.
ZA962821B (en) 4-indolylpiperazinyl derivatives.
ZA969625B (en) 25-Hydroxy-16-ene-26, 27-bishomo-cholecalciferols
ZA962753B (en) 1,3-Dihydro-2H-imidazol-2-one derivatives.
ZA966399B (en) Endothelin-receptor-antagonists.
ZA965292B (en) Enzymatic composition.
ZA967357B (en) Pyrazol-4-ylbenzoyl derivatives.
ZA967545B (en) Pharmaceuticals.
ZA964879B (en) Starch microsphere anti migraine composition.
ZA967997B (en) Urea derivatives.
ZA966750B (en) Halogenobenzimidazoles.